Antibiotic‐Free Management of Canine Pyometra With Aglepristone: Endocrine Effects and Post‐Treatment Vaginal Hyperplasia
Reproduction in Domestic Animals · 2025
DOI: 10.1111/rda.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction in Domestic Animals, 2025. Verfasst von Thiago Vaz Lopes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Veterinária, Universidade Federal Do Acre, Rio Branco, Brazil. Hauptthemen laut MEDLINE: Pyometra, Dog Diseases, Estrenes, Vagina. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
This study evaluated the clinical efficacy of aglepristone for the management of canine pyometra—either as a sole therapy or in combination with different antibiotic regimens—and investigated the association between aglepristone dosing and the occurrence of vaginal hyperplasia during the subsequent estrous cycle. Eighty‐seven intact bitches diagnosed with pyometra were enrolled and divided into two experiments. In Experiment I, 57 bitches were randomly assigned to three treatment groups ( n = 19/group): (1) AGL, aglepristone alone; (2) AGL‐CEF, aglepristone plus ceftriaxone; and (3) AGL‐CEF‐MET, aglepristone plus ceftriaxone and metronidazole. Clinical examinations and haematological and biochemical profiles were assessed every 48 h for 15 days. In Experiment II, 30 bitches were treated with aglepristone using two protocols: AGL 4X (10 mg/kg s.c. on Days 0, 1, 8 and 15) or AGL 2X (10 mg/kg s.c. on Days 0 and 1). Incidence and severity of vaginal hyperplasia, as well as post‐treatment reproductive performance, were evaluated during the subsequent oestrus. All three treatment protocols achieved clinical resolution of pyometra—including the aglepristone‐only group—with normalisation of leukocyte counts and serum biochemical markers. In Experiment II, vaginal hyperplasia occurred in 53.3% of bitches in the AGL 4X group versus 7% in the AGL 2X group. Grade III hyperplasia was associated with pyometra recurrence and reduced pregnancy rates. Overall pregnancy rate in Experiment II was 80%. These findings indicate that aglepristone is an effective, fertility‐preserving treatment for canine pyometra, even when administered without systemic antibiotics. However, high‐dose or prolonged administration may induce oestrogen‐mediated adverse effects such as vaginal hyperplasia and disease recurrence. A reduced dosing regimen appears safer while maintaining equivalent clinical and reproductive efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Medicina Veterinária, Universidade Federal Do Acre, Rio Branco, Brazil.
- Pontifícia Universidade católica Do Paraná, Curitiba, Brazil.
- Universidade Federal Do Paraná, Curitiba, Brazil.
ORCID-Profile: Luiz Ernandes Kozicki, Natália Siqueira de Lara
Zitieren
APA
Lopes, T. V., Kozicki, L. E., de Lima, P. H. L., de Lara, N. S., Silvestri, M., Vaz, E. S., Morettini E Castella, R., Laskoski, L. M., & Souza, F. A. (2025). Antibiotic‐Free Management of Canine Pyometra With Aglepristone: Endocrine Effects and Post‐Treatment Vaginal Hyperplasia. Reproduction in Domestic Animals. https://doi.org/10.1111/rda.70127
Vancouver
Lopes TV, Kozicki LE, de Lima PHL, de Lara NS, Silvestri M, Vaz ES, et al. Antibiotic‐Free Management of Canine Pyometra With Aglepristone: Endocrine Effects and Post‐Treatment Vaginal Hyperplasia. Reproduction in Domestic Animals. 2025. doi:10.1111/rda.70127
BibTeX
@article{Lopes2025,
author = {Lopes, Thiago Vaz and Kozicki, Luiz Ernandes and de Lima, Pedro Henrique Lomba and de Lara, Natália Siqueira and Silvestri, Mayara and Vaz, Eduarda Stankiwich and Morettini E Castella, Rafaela and Laskoski, Luciane Maria and Souza, Fernando Andrade},
title = {Antibiotic‐Free Management of Canine Pyometra With Aglepristone: Endocrine Effects and Post‐Treatment Vaginal Hyperplasia},
journal = {Reproduction in Domestic Animals},
year = {2025},
doi = {10.1111/rda.70127}
}
EUVIMED